Status:
COMPLETED
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)
Lead Sponsor:
Organon and Co
Conditions:
Pregnancy
Neonates
Eligibility:
FEMALE
18-36 years
Brief Summary
The objective of this follow-up study is to evaluate whether corifollitropin alfa (Org 36286) treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (...
Detailed Description
This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal outcome of women who were treated with corifollitropin alfa or recFSH and became pregnant during the base study ...
Eligibility Criteria
Inclusion
- Participants who participated in base study P05690 (NCT00702845) and received at least one dose of either corifollitropin alfa (Org 36286) or recFSH in base study P05690;
- Ongoing pregnancy confirmed by ultrasound at least 10 weeks after embryo transfer in base study P05690;
- Able and willing to give written informed consent.
Exclusion
- None
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT00702624
Start Date
April 1 2007
End Date
June 1 2008
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.